OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 01, 2021
New biologic modalities, such as cell and gene therapies, pose increasing difficulties in viral clearance testing methods.
June 01, 2021
Recent innovations in chromatography resins offer promising advantage in downstream bioprocessing.
April 16, 2021
Sartorius has expanded in the United Kingdom with the relocation to a new facility in Havant, Hampshire, for downstream processing equipment.
April 01, 2021
The adoption of single-use technologies in fluid-handling systems helps streamline downstream bioprocessing operations.
March 02, 2021
The need for real-time monitoring and control has spurred the development of new analytical tools.
February 01, 2021
A unified scale-up approach, as presented here, can be applied to any unit operation.
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
Cytiva acquired Vanrx Pharmasystems, a Canadian manufacturer of robotic aseptic filling equipment.
January 28, 2021
The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A platform.
December 02, 2020
Viral clearance processes and guidance must evolve along with newer biotherapeutic modalities.